MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$37,228K
Net Income
-$56,159K
Net Profit Margin
-150.85%
EPS
-$0.44
Unit: Thousand (K) dollars
Revenue Breakdown
    • Advanced Wound Care
    • Surgical And Sports Medicine
    • Grant

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue
37,228 225,607 150,864 101,005
Cost of goods sold
25,772 73,641 36,251 27,630
Selling, general and administrative
65,186 100,174 79,743 73,810
Research and development
15,161 10,286 13,221 10,395
Write-down to fair value for asset held for sale
NaN 1,940 922 1,746
Total operating expenses
106,119 186,041 130,137 113,581
Loss from operations
-68,891 63,289 20,727 -12,576
Interest income, net
-380 -236 -415 -669
Other income, net
38 -98 18 73
Total other income, net
418 138 433 742
Net loss before income taxes
-68,473 63,427 21,160 -11,834
Income tax benefit
-15,317 19,727 -407 -2,442
Net loss and comprehensive loss
-53,156 43,700 21,567 -9,392
Accretion of redeemable convertible preferred stock to redemption value
159 150 140 129
Cumulative dividend on redeemable convertible preferred stock
2,844 2,788 2,734 2,681
Undistributed earnings allocated to participating redeemable convertible preferred stock
NaN 1,472 4,168 NaN
Net loss attributable to common stockholders, basic, total
-56,159 39,290 14,525 -12,202
Basic EPS
-0.44 0.31 0.11 -0.1
Diluted EPS
-0.44 0.287 0.11 -0.1
Basic Average Shares
127,797,013 126,921,657 126,881,709 126,853,536
Diluted Average Shares
127,797,013 136,995,475 130,848,995 126,853,536
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net lossattributable to common...-$56,159K (-160.10%↓ Y/Y)Net loss andcomprehensive loss-$53,156K (-182.10%↓ Y/Y)Cumulative dividend onredeemable convertible...$2,844K (8.26%↑ Y/Y)Accretion of redeemableconvertible preferred stock...$159K (31.40%↑ Y/Y)Income tax benefit-$15,317K (-120.71%↓ Y/Y)Interest income, net-$380K (60.46%↑ Y/Y)Other income, net$38K (1800.00%↑ Y/Y)Advanced Wound Care$29,482K Surgical And SportsMedicine$6,768K Net loss beforeincome taxes-$68,473K (-165.57%↓ Y/Y)Total other income,net$418K (-56.59%↓ Y/Y)Product$36,250K Grant$978K Loss from operations-$68,891K (-157.57%↓ Y/Y)Total revenue$37,228K (-57.06%↓ Y/Y)Total operatingexpenses$106,119K (18.28%↑ Y/Y)Selling, general andadministrative$65,186K (-10.10%↓ Y/Y)Cost of goods sold$25,772K (8.64%↑ Y/Y)Research and development$15,161K (42.49%↑ Y/Y)

Organogenesis Holdings Inc. (ORGO)

Organogenesis Holdings Inc. (ORGO)